Cogent Biosciences, Inc.COGTNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P24
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.36% |
| Q3 2025 | -10.28% |
| Q2 2025 | -0.87% |
| Q1 2025 | -1.63% |
| Q4 2024 | 2.23% |
| Q3 2024 | -17.13% |
| Q2 2024 | -3.18% |
| Q1 2024 | -7.17% |
| Q4 2023 | 2.27% |
| Q3 2023 | -26.54% |
| Q2 2023 | -8.90% |
| Q1 2023 | 1.16% |
| Q4 2022 | -18.80% |
| Q3 2022 | -2.69% |
| Q2 2022 | -14.12% |
| Q1 2022 | -22.54% |
| Q4 2021 | -29.37% |
| Q3 2021 | -14.61% |
| Q2 2021 | -35.09% |
| Q1 2021 | -11.73% |
| Q4 2020 | 79.97% |
| Q3 2020 | -672.65% |
| Q2 2020 | -20.55% |
| Q1 2020 | -374.15% |
| Q4 2019 | 118.61% |
| Q3 2019 | -14.18% |
| Q2 2019 | 10.98% |
| Q1 2019 | -31.51% |
| Q4 2018 | 14.86% |
| Q3 2018 | -12.05% |
| Q2 2018 | -35.11% |
| Q1 2018 | -1.54% |
| Q4 2017 | 4.04% |
| Q3 2017 | -18.85% |
| Q2 2017 | 0.59% |
| Q1 2017 | 0.00% |
| Q3 2016 | 0.00% |
| Q3 2015 | 0.00% |